MedTrace Logo

Efficacy of a Two-Year Intensive Reading Intervention for Middle School English Learners With Reading Difficulties

NCT03695068 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 840

Last updated 2022-05-23

No results posted yet for this study

Summary

This study investigates the efficacy of a reading comprehension intervention for English learners in Grades 6 and 7 with reading difficulties. Building on previous intervention studies conducted with students in Grades 4 through 8 over the past 10 years, the investigators utilize a longitudinal, double-cohort design utilizing a randomized control trial assigning students to supplemental reading intervention (RISE) or a no intervention "business as usual" (BAU) comparison condition (i.e., Cohort 1 - Years 1 and 2; 205 students in treatment and 205 in control condition; Cohort 2 - Years 3 and 4; 205 students in treatment and 205 in control condition; total 410 in each condition). Students in each cohort will be treated for 2 years (i.e., 6th and 7th grades or 7th and 8th grades). The primary outcome is reading comprehension.

The investigators hypothesize that participants receiving the RISE intervention will outperform those receiving BAU instruction across reading-related elements, including word reading, fluency, and comprehension at end of year two of treatment.

Conditions

  • Learning Disorders
  • Dyslexia

Interventions

BEHAVIORAL

RISE Intervention

Described in Arms description.

Sponsors & Collaborators

  • University of Texas at Austin

    collaborator OTHER

  • The University of Texas Health Science Center, Houston

    collaborator OTHER

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • University of Houston

    lead OTHER

Principal Investigators

  • Jack M Fletcher, Ph.D. · University of Houston

  • Sharon Vaughn, Ph.D. · University of Texas at Austin

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2022-06-15
Completion
2022-06-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03695068 on ClinicalTrials.gov